PyInvesting

Market research

300289.SHE Beijing Leadman Biochemistry Co.,Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
Not available
Analyst target
17
Dividend yield
Not available
Beta
0.21

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Beijing Leadman Biochemistry Co.,Ltd is currently in a long term downtrend where the price is trading 6.5% below its 200 day moving average.

From a valuation standpoint, the stock is 48.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.

Beijing Leadman Biochemistry Co.,Ltd's total revenue rose by 34.8% to $149M since the same quarter in the previous year.

Its net income has increased by 322.0% to $11M since the same quarter in the previous year.

Finally, its free cash flow grew by 87.2% to $47M since the same quarter in the previous year.

Based on the above factors, Beijing Leadman Biochemistry Co.,Ltd gets an overall score of 4/5.